A carregar...
Publicação
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 910.65 KB | Adobe PDF |
Orientador(es)
Resumo(s)
Suppressor of Tumorigenicity 2 (ST2) is an IL33 receptor detected in the mucosa and serum of ulcerative colitis (UC) patients. We evaluated soluble ST2 (sST2) as a surrogate biomarker of disease outcome and therapeutic response, in moderate-to-severe UC patients treated with golimumab.
Descrição
Palavras-chave
Endoscopic activity Golimumab Histological activity Serum soluble ST2 Ulcerative colitis
Contexto Educativo
Citação
Editora
SAGE Publications